why choose us

First received: September 19, 2023

Clinical Trial: CX3CR1+T Cell Predict Immunotherapy Efficacy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-small Cell Lung Cancer

Study Type: OBSERVATIONAL


Official Title: Prediction of Immunotherapy Efficacy Based on Transcriptome of CX3CR1+T Cell in Peripheral Blood

Brief Summary: This study aimed to evaluate the correlation between the proportion of flow-sorted CX3CR1+T cells in peripheral blood and the CX3CR1+T-specific gene signature and the efficacy of immunotherapy.

Read more